Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.001
Trevena Inc Aktie (TRVN) Neueste Nachrichten
Armistice Capital (TRVN) discloses 9.91% Trevena stake via Master Fund - Stock Titan
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight - PR Newswire UK
If You Invested $1,000 in Endonovo Therape (ENDV) - Stock Titan
If You Invested $1,000 in Globestar Therapeutics Corp (GSTC) - Stock Titan
If You Invested $1,000 in Altamira Therapeutics Ltd (CYTOF) - Stock Titan
Enterprise value to EBIT forward of Trevena, Inc. – OTC:TRVN - TradingView
Price to earnings forward of Trevena, Inc. – OTC:TRVN - TradingView
Enterprise value to revenue forward of Trevena, Inc. – OTC:TRVN - TradingView
Trevena, Inc. Actuals & Estimates (GETTEX:6T4) - TradingView
Enterprise value to EBITDA forward of Trevena, Inc. – OTC:TRVN - TradingView
Trevena, Inc. Actuals & Estimates (LS:A40L1Y) - TradingView
Trevena, Inc. Actuals & Estimates (OTC:TRVN) - TradingView
Chronic and Acute Pain Pipeline Insights Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com
Most US Treasury Yields Fall Pre-Bell After Iran State Media Reports Tehran-US Peace Agreement to Reopen Hormuz - marketscreener.com
Trevena Inc Stock (US89365K1007): sector backdrop for a biotech in focus - AD HOC NEWS
Diabetic Peripheral Neuropathy Pipeline Accelerates as 15+ - openPR.com
Opioids Market Size, Share, Growth, Analysis, Report, 2034 - Straits Research
S&P Futures Up 0.1% - marketscreener.com
Trevena Inc stock (US89365K1007): low-priced biotech name draws speculative interest despite limited - AD HOC NEWS
Europe Stocks: Research Stocks from Europe Stock Market - GuruFocus
Number of shareholders of Trevena, Inc. – OTC:TRVN - TradingView
Trevena Inc stock (US89365K1007): biotech minnow fights for time after Nasdaq delisting and restruct - AD HOC NEWS
Number of shareholders of Trevena, Inc. – MUN:6T4 - TradingView
Trevena stock (US89365K1007): pipeline setbacks, Nasdaq pressure and what investors should know now - AD HOC NEWS
S&P Futures Down 1% - marketscreener.com
Trevena Inc stock (US89365K1007): Trading at $0.011 amid biopharma challenges - AD HOC NEWS
Catalent, Inc. Common Stock (NY: CTLT - FinancialContent
Trevena Inc (TRVN) Stock Price & 30 Year Financial Data - GuruFocus
Trevena Inc (TRVN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Trevena Inc (OTCM:TRVN) Stock Earnings Transcripts - GuruFocus
Trevena Inc (OTCM:TRVN) Dividend - GuruFocus
Trevena Inc (OTCM:TRVN) SEC filings - GuruFocus
Trevena Inc (OTCM:TRVN) Insider Trading Activity | Apple Insider Buys and Sells - GuruFocus
Trevena Inc stock (US89365K1007): Biopharma firm focuses on pain and CNS pipeline amid cash burn con - AD HOC NEWS
Health News Round upopioid pain drugs, Ebola vaccinations in Uganda and much mmore - Devdiscourse
Diabetic Neuropathy Pipeline Set for Significant - openPR.com
Diabetic Neuropathy Pipeline Set for Significant Breakthroughs by 2026 with 20+ Therapies and Robust Clinical Advancements | DelveInsight - Barchart.com
Nasdaq Composite closes down 222.37 points, or 0.89%, to 24,664.73 - marketscreener.com
Polaris Venture Partners V L P Net WorthInsider Trades and Bio as of Apr 22, 2026 - Benzinga
Verastem, Inc. (VSTM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight - Barchart.com
TherapeuticsMD, Inc. (TXMD) stock price, news, quote and history - Yahoo Finance UK
Trevena (STU:6T4) PB Ratio : (As of Mar. 28, 2026) - gurufocus.com
Stock List: Research Stocks from Around the World - GuruFocus
SMX (Security Matters) Public Limited CompanyOrdinary Shares (NQ: SMX - The Chronicle-Journal
Wall Street closes lower, as war on Iran fuels inflation worries - marketscreener.com
S&P Closes Out Third Straight Week of Loses | Closing Bell - marketscreener.com
US Stocks Brief: S&P Futures Down 0.25% - marketscreener.com
Elon Musk's SpaceX weighs Nasdaq listing, sources say - marketscreener.com
Celebrity-studded Caliwater bets cactus is next big wave in hydration - Food Dive
Wall Street opens lower as investors weigh Middle East war risks - marketscreener.com
TRVN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Trump Says Stock Market Hit 53 New Highs on His Watch - marketscreener.com
US software stocks climb as Anthropic announcement sparks relief rally - marketscreener.com
VINC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Tg-17 Inc changes corporate name to Our Bond, Inc. - marketscreener.com
GreenPower Motor Regains Nasdaq Compliance - marketscreener.com
Investor Increases its Stake in Nasdaq - marketscreener.com
Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn - marketscreener.com
Columbus Circle Capital Corp II Prices $200 Million Initial Public Offering - marketscreener.com
Spring Valley Acquisition Corp. IV Prices $200 Million IPO - marketscreener.com
Caliwater hires first CEO - Food Business News
SpyGlass Pharma Prices $150 Million IPO - marketscreener.com
Nasdaq proposes 'fast entry' rule to speed up index inclusion of large new listings - marketscreener.com
RCI Hospitality Receives Non-Compliance Letter from Nasdaq - marketscreener.com
Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire
North American Morning Briefing : Nasdaq Futures Rise; Trade Relations, Earnings in Focus -2 - marketscreener.com
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - The Manila Times
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: - GlobeNewswire
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors - BioSpace
0.00%
3.22%
Kapitalisierung:
|
Volumen (24h):